Antibe Therapeutics Inc. announced that it has established a strategic advisory board to support its business development activities. The advisory board consists of recognized industry leaders: Angus Russell, Dominique Monnet, Andrew Powell and Rami Batal. Angus Russell was the CEO of Shire from 2008 until his retirement in 2013. He currently serves as the Chairman of Mallinckrodt. Dominique Monnet has more than 35 years of leadership experience in the biopharma industry, in the U.S. and internationally. He served as Senior Vice President and Chief Marketing Officer of Alexion in 2014 to 2015. He is currently President of PDL BioPharma, which manages a portfolio of companies, products and royalty agreements in the healthcare sector. Andrew Powell is highly regarded for his ability to strategically position life science assets and companies for a monetization event. He currently serves as a director at Aclaris Therapeutics and as a director at Landec. Rami Batal was most recently a senior business development officer for Purdue Canada and brings to Antibe vast experience in the pain markets. Currently, Rami is Vice President, Medical Research of Canopy Growth.